Jan 24 (Reuters) - Empir Group AB (publ) EMPIRb.ST :
* SAID ON FRIDAY ENTERED INTO A LETTER OF INTENT FOR A
POTENTIALLY
REVERSE ACQUISITION OF VIVABEM BRASIL AB (VIBE)
* VIVABEM BRASIL AB IS BRAZIL'S LARGEST PLAYER IN DIGITAL
HEALTH
AIMED AT CONSUMERS
* THE INDICATIVE PURCHASE PRICE FOR ALL EXISTING SHARES IN
VIBE IS
TENTATIVELY ESTIMATED AT ABOUT SEK 2,250 MILLION ($244.45
MILLION), WHICH IS THE SUBJECT OF FINAL NEGOTIATIONS
* THE GOAL IS TO COMPLETE THE TRANSACTION DURING Q1 2022
* IN CONNECTION WITH THE COMPLETION OF THE TRANSACTION,
EMPIR
INTENDS TO CHANGE MANAGEMENT, BOARD AND MARKETPLACE FROM NASDAQ
STOCKHOLM'S SMALL CAP LIST TO NASDAQ FIRST NORTH GROWTH MARKET
AND TO CHANGE ITS NAME TO VIBE GROUP AB (PUBL)
* TRANSACTION WOULD MEAN THAT EMPIR CHANGES ITS BUSINESS
FOCUS TO
BECOME A DIGITAL HEALTHCARE COMPANY WITH A FOCUS ON BRAZIL
THROUGH THE SUBSIDIARY VIBE
Source text for Eikon: urn:newsml:reuters.com:*:nWkrbVkgtM
Further company coverage: EMPIRb.ST
($1 = 9.2044 Swedish crowns)
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))